Molecular mechanisms of estrogen actions on the vasculature

Journal of Nuclear Cardiology

Volumn 7, Issue 5, 2000, Pages 500-508

  Haynes, M Page ^a   Russell, Kerry Strong ^a   Bender, Jeffrey R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIC GMP; DNA; ENDOTHELIUM DERIVED RELAXING FACTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FIBRINOGEN; FULVESTRANT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE SYNTHASE; PLASMINOGEN; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOMATOMEDIN C; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CELL ACTIVITY; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; ESTROGEN ACTIVITY; ESTROGEN THERAPY; GENE EXPRESSION; GENOME; HEART PROTECTION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

EID: 0033762541     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2000.109958     Document Type: Article

References (67)

1. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The postmenopausal estrogen/progestin intervention (PEPI) trial
2. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
3. Design of the women's health initiative clinical trial and observational study
4. Hormones and vasoprotection
5. Estrogens for prevention of coronary heart disease: Putting the brakes on the bandwagon
6. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women
7. The nuclear receptor superfamily: The second decade
8. Estrogen receptor molecular biology
9. A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5'-TAGACC-3' motifs acting synergistically
10. Human estrogen receptor forms multiple protein-DNA complexes
11. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1
12. Cross-talk between peptide growth factor and estrogen receptor signaling pathways
13. Isolation and chromosomal localization of the human eNOS gene
14. 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization
15. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling
16. Sequence and expression of human estrogen receptor complementary DNA
17. Human oestrogen receptor cDNA sequence expression and homology to v-erb-A
18. Cloning of a novel receptor expressed in rat prostate and ovary
19. Cloning, chromosomal localization and functional analysis of the murine estrogen receptor beta
20. The protective effects of estrogen on the cardiovascular system
21. Molecular basis of agonism and antagonism in the oestrogen receptor
22. Estrogen receptors alpha and beta form heterodimers on DNA
23. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha
24. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function
25. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells
26. Human vascular smooth muscle cells contain functional estrogen receptor
27. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury
28. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta
29. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium
30. Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization
31. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling
32. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide
33. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: Implications for caveolae localization
34. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1
35. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae
36. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP
37. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells
38. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo
39. Dynamic activation of endothelial nitric oxide synthase by Hsp90
40. Signal transduction of eNOS activation
41. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
42. Enhanced electron flux and reduced calmodulin dissociation may explain ″calcium-independent″ eNOS activation by phosphorylation
43. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells
44. Autoinhibition of endothelial nitric-oxide synthase. Identification of an electron transfer control element
45. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
46. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium
47. Upregulation of nitric oxide synthase by estradiol in human aortic endothelial cells
48. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
49. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation
50. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
51. Nitric oxide: An endogenous modulator of leukocyte adhesion
52. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP
53. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium
54. Estrogen effects on insulin-like growth factor-I (IGF-I)-induced cell proliferation and IGF-I expression in native and allograft vessels
55. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro
56. Endothelial expression of mononuclear leukocyte adhesion molecule during atherogenesis
57. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression
58. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: Possible mechanisms for gender differences in atherosclerosis
59. Estradiol suppresses MCP-1 expression in vivo: Implications for atherosclerosis
60. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model
61. Estradiol accelerates functional endothelial recovery after arterial injury
62. Estrogen restores endothelial cell function in an experimental model of vascular injury
63. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis: Estradiol as a survival factor
64. Estrogen inhibits the response-to-injury in a mouse carotid artery model
65. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice
66. Generation and reproductive phenotypes of mice lacking estrogen receptor beta
67. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice